| Name | Title | Contact Details |
|---|---|---|
Jim Graham |
Chief Information Officer | Profile |
Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.
Enochian BioSciences (formerly DanDrit Biotech USA Inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for HIV/AIDS and cancer.
Brundage Group is a company that provides revenue cycle solutions for hospitals, including physician advisory services, staffing solutions, and documentation education.
Buffalo Hospital Supply Co Inc is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Morris and Associates is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.